Accelerated Pharma (Accelerated Pharma) Other Long Term Assets : $0.13 Mil (As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Other Long Term Assets?

Accelerated Pharma's other long-term assets for the quarter that ended in Mar. 2017 was $0.13 Mil.

Accelerated Pharma's quarterly other long-term assets declined from Sep. 2016 ($0.08 Mil) to Dec. 2016 ($0.07 Mil) but then increased from Dec. 2016 ($0.07 Mil) to Mar. 2017 ($0.13 Mil).

Accelerated Pharma's annual other long-term assets increased from Dec. 2014 ($0.00 Mil) to Dec. 2015 ($0.09 Mil) but then declined from Dec. 2015 ($0.09 Mil) to Dec. 2016 ($0.07 Mil).

Accelerated Pharma Other Long Term Assets Historical Data

The historical data trend for Accelerated Pharma's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Other Long Term Assets Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Other Long Term Assets

0.09

0.07

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Other Long Term Assets	Get a 7-Day Free Trial			-	-	0.08	0.07	0.13

Accelerated Pharma Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines